These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8705862)

  • 1. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.
    Sigalas I; Calvert AH; Anderson JJ; Neal DE; Lunec J
    Nat Med; 1996 Aug; 2(8):912-7. PubMed ID: 8705862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
    Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
    Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative and aberrant splicing of MDM2 mRNA in human cancer.
    Bartel F; Taubert H; Harris LC
    Cancer Cell; 2002 Jul; 2(1):9-15. PubMed ID: 12150820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis.
    Steinman HA; Burstein E; Lengner C; Gosselin J; Pihan G; Duckett CS; Jones SN
    J Biol Chem; 2004 Feb; 279(6):4877-86. PubMed ID: 14612455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
    Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
    Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MDM2 during mammary tumorigenesis.
    Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
    Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
    Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
    Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53.
    Perry ME; Mendrysa SM; Saucedo LJ; Tannous P; Holubar M
    J Biol Chem; 2000 Feb; 275(8):5733-8. PubMed ID: 10681559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
    Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
    Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
    Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
    Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
    Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
    Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
    Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
    Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement.
    Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M
    Pathol Int; 2000 Oct; 50(10):786-92. PubMed ID: 11107050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
    Bartel F; Taylor AC; Taubert H; Harris LC
    Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the MDM2 oncogene in leukemia and lymphoma.
    Watanabe T; Ichikawa A; Saito H; Hotta T
    Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and MDM2 in the development and progression of bladder cancer.
    Schmitz-Dräger BJ; Kushima M; Goebell P; Jax TW; Gerharz CD; Bültel H; Schulz WA; Ebert T; Ackermann R
    Eur Urol; 1997; 32(4):487-93. PubMed ID: 9412812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.